Neurocrine Biosciences
NBIX
#1890
Rank
$7.14 B
Marketcap
$75.35
Share price
4.00%
Change (1 day)
-34.61%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: $7.14 Billion

As of January 2022 Neurocrine Biosciences has a market cap of $7.14 Billion. This makes Neurocrine Biosciences the world's 1890th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Neurocrine Biosciences from 2001 to 2022

Year Market cap Change
2022$7.12 B-11.74%
2021$8.07 B-9.86%
2020$8.95 B-9.71%
2019$9.91 B52.97%
2018$6.48 B-5.57%
2017$6.86 B104.23%
2016$3.36 B-31.11%
2015$4.87 B185.67%
2014$1.70 B171.56%
2013$0.62 B26.57%
2012$0.49 B5.82%
2011$0.46 B12.02%
2010$0.41 B250.42%
2009$0.11 B-3.12%
2008$0.12 B-28.92%
2007$0.17 B-56.01%
2006$0.39 B-83.04%
2005$2.32 B29.33%
2004$1.80 B-6.48%
2003$1.92 B37.56%
2002$1.40 B-10.09%
2001$1.55 B

End of Day market cap according to different sources

On Jan 27th, 2022 the market cap of Neurocrine Biosciences was reported to be:

$6.87 Billion
by Yahoo Finance
$6.87 Billion
by CompaniesMarketCap
$6.87 Billion
by Nasdaq
$6.90 Billion
by Reuters
$6.86 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap difference Country
$303.93 B 4,152.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$240.69 B 3,267.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$229.98 B 3,117.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.27 B 43.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.19 B-97.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.08 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.65 B 132.97%๐Ÿ‡ฌ๐Ÿ‡ง UK